Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043079 · ClinicalTrials.gov registry record · NA
Ultrasound Assessment of Ventral Hernia Defects
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03043079: Completed NA study, sponsored by University of Pennsylvania.
NCT03043079 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03043079, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Quantitative radiographic imaging holds promise as a novel and innovative strategy to assess ventral hernia patients. Assessing abdominal wall changes surrounding ventral hernia using shear wave velocity values measured with ultrasound will identify features of the abdominal wall that differ between healthy volunteers and subjects scheduled to have ventral hernia repair. Through the use of ultrasound including shear wave velocity measurements, the abdominal wall of 25 subjects scheduled to have ventral hernia repair will be compared to those of 35 healthy volunteers. The ultrasound measurements will elucidate if ventral hernia affects abdominal wall elasticity and effect surgical outcomes.
Primary Outcome
Differences in the shear wave velocity measurements in the abdominal wall of healthy and ventral hernia patients
Interventions
- DIAGNOSTIC_TEST Ultrasound Acoustic Radiation Forced Impulse Shear Wave Velocity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-09-15 |
| Phase | NA |
What the finished NCT03043079 record still lists
NCT03043079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Ultrasound Acoustic Radiation Forced Impulse Shear Wave Velocity is the first listed.
NCT03043079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03043079 about?
NCT03043079 is a clinical study titled "Ultrasound Assessment of Ventral Hernia Defects". Quantitative radiographic imaging holds promise as a novel and innovative strategy to assess ventral hernia patients. Assessing abdominal wall changes surrounding ventral hernia using shear wave velocity values measured with ultrasound will identify features of the abdominal wall that differ between...
What is the current status of trial NCT03043079?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-04. Estimated completion is 2017-09-15.
What interventions are being tested in trial NCT03043079?
The interventions under investigation include: Ultrasound Acoustic Radiation Forced Impulse Shear Wave Velocity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03043079?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03043079's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia